ESPN |
How Colorado’s Derek McCartney was the perfect match to save a …
ESPN When Colorado’s Derek McCartney took part in the Be The Match program, he never thought it’d lead to donating bone marrow that would save 64-year-old … |
WealthManagement.comKey Provisions of the Tax Cuts and Jobs Act for Tax-Exempt OrganizationsLexology2, 2017, when House Ways and Means Committee Chair Kevin Brady (R-Texas) introduced H.R.1, the Tax Cuts and Jobs Act. Several provisions of the legislat…
Channel NewsAsia |
Trump, Clinton camps both offered slice of dossier firm’s work – sources
Channel NewsAsia The same political research firm that prepared a dossier on Trump campaign ties to Russia had unrelated information on Clinton Foundation donors that a Russian lawyer obtained and offered to President Donald Trump’s eldest son last year, three sources … Russian lawyer who met with Trump Jr. offered him info from firm behind Trump dossier: reportThe Hill Fusion GPS Reportedly Provided Dirt to Both Clinton and Trump CampaignsMediaite New Book Details Hillary’s Attempt to Undo ElectionNational Legal and Policy Center |
Reuters |
Trump, Clinton camps both offered slice of dossier firm’s work: sources
Reuters WASHINGTON (Reuters) – The same political research firm that prepared a dossier on Trump campaign ties to Russia had unrelated information on Clinton Foundation donors that a Russian lawyer obtained and offered to President Donald Trump’s eldest son … Fusion GPS Reportedly Provided Dirt to Both Clinton and Trump CampaignsMediaite New Book Details Hillary’s Attempt to Undo ElectionNational Legal and Policy Center |
Reuters |
Trump, Clinton camps both offered slice of dossier firm’s work: sources
Reuters WASHINGTON (Reuters) – The same political research firm that prepared a dossier on Trump campaign ties to Russia had unrelated information on Clinton Foundation donors that a Russian lawyer obtained and offered to President Donald Trump’s eldest son … |
Immuno-Oncology News |
FDA Lifts Clinical Hold on Cellectis’ UCART123 Phase 1 Trials in AML, BPDCN
Immuno-Oncology News The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on Cellectis’ Phase 1 trials of UCART123 in acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN), allowing the company to resume the studies with an … |
What Patients With Cancer Can Learn from Savvy ShoppersCuretoday.comOf those enrolled, 31 percent were at high-risk of CMV. Treatment included myeloablative conditioning for 50 percent of patients and 35 percent received ATG. In addition to related don…
Wichita EagleLetermovir Granted FDA Approval for CMV Prophylaxis After Transplantwww.oncnursingnews.com/In addition to related donors, HSCT also consisted of mismatched unrelated donors (14%), haploidentical donors (13%), and cord blood (4%). The prima…
Wichita EaglePrevymis Approved to Prevent Virus in Patients Receiving Stem Cell TransplantsCuretoday.comOf those enrolled, 31 percent were at high-risk of CMV. Treatment included myeloablative conditioning for 50 percent of patients and 35 percent rece…
Bellicum Reports Third Quarter 2017 Financial Results | Markets …Markets InsiderHOUSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular …and more »